SCHEMBL30029104

SCHEMBL30029104

CC(C)(C)OC(=O)N[C@@H](CCCCNC(=O)OCCN=[N+]=[N-])C(=O)O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.45
▸ KMT2A Q03164 2/20 0.45
▸ GAA P10253 1/20 0.45
▸ ALDH1A1 P00352 1/20 0.44
▸ TSHR P16473 1/20 0.44
▸ KLK7 P49862 2/20 0.41
▸ KLK5 Q9Y337 2/20 0.41
▸ CTSS P25774 1/20 0.41
▸ CTSK P43235 1/20 0.41
▸ MAPT P10636 2/20 0.41
▸ CAPN1 P07384 1/20 0.40
▸ TDP1 Q9NUW8 4/20 0.40
▸ ATM Q13315 2/20 0.40
▸ TGM2 P21980 2/20 0.39
▸ POLB P06746 2/20 0.39
▸ NPSR1 Q6W5P4 2/20 0.39
▸ CA12 O43570 2/20 0.39
▸ CA1 P00915 2/20 0.39
▸ CA2 P00918 2/20 0.39
▸ CA9 Q16790 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23278802 1.00 MEN1 (0.45) MEN1KMT2AGAAALDH1A1TSHR
SCHEMBL30030056 0.92 TDP1 (0.47) MEN1KMT2AGAAALDH1A1KLK7
SCHEMBL29796125 0.86 CAPN1 (0.46) MEN1KMT2AGAAALDH1A1TSHR
SCHEMBL14439650 0.85 ALDH1A1 (0.46) MEN1KMT2AGAAALDH1A1TSHR
SCHEMBL15888952 0.85 ALDH1A1 (0.46) MEN1KMT2AGAAALDH1A1TSHR
SCHEMBL15498945 0.85 CAPN1 (0.47) MEN1KMT2AGAAALDH1A1TSHR
SCHEMBL30895514 0.85 ALB (0.43) MEN1KMT2AGAAALDH1A1TSHR
SCHEMBL15625939 0.84 ALDH1A1 (0.46) MEN1KMT2AGAAALDH1A1TSHR
SCHEMBL14674508 0.84 ALDH1A1 (0.46) MEN1KMT2AGAAALDH1A1TSHR
SCHEMBL16013190 0.84 TGM2 (0.43) TGM2FOLH1ITGB3ALB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12577197-B2 Methods of preparing N6-((2-azidoethoxy)carbonyl)lysine SANOFI (FR) 2026-03-17 — — US disclosed
US-20220324792-A1 METHODS OF PREPARING N6-((2-AZIDOETHOXY)CARBONYL)LYSINE Synthorx, Inc. (US) 2022-10-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220324792-A1 METHODS OF PREPARING N6-((2-AZIDOETHOXY)CARBONYL)LYSINE JMJD6, LOX, KDM6B MEN1 3724/4885KMT2A 198/4885GAA 974/4885
US-12577197-B2 Methods of preparing N6-((2-azidoethoxy)carbonyl)lysine JMJD6, PHF2, KDM2A MEN1 3980/4885KMT2A 227/4885GAA 3071/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback